| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |